News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Novartis AG Insider Reinhardt May be Next CEO
October 21, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ZURICH/LONDON (Reuters) - Novartis seems to be lining up a smooth transition at the top, with respected insider Joerg Reinhardt moving into pole position to eventually replace the company's veteran chief executive, Daniel Vasella.
Twitter
LinkedIn
Facebook
Email
Print
People
Europe
Novartis
MORE ON THIS TOPIC
Immunology and inflammation
Novartis Unites With Relation in $1.7B Inflammatory Skin Disease Pact
December 9, 2025
·
2 min read
·
Tristan Manalac
Cancer
GSK Cuts Five-Year-Old Cancer Collaboration With Ideaya
December 8, 2025
·
2 min read
·
Tristan Manalac
Collaboration
Crescent, Kelun-Biotech Swap Therapies in ADC-Bispecific Deal Worth Up To $1.25B
December 4, 2025
·
2 min read
·
Tristan Manalac
Opinion
Even Early Stage Biotechs Can’t Ignore Tariffs
December 3, 2025
·
4 min read
·
Josh Medow